Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study

Shinji Tanaka, Kaoru Mogushi, Mahmut Yasen, Daisuke Ban, Norio Noguchi, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Hiroshi Tanaka, Masakazu Yamamoto, Norihiro Kokudo, Tadatoshi Takayama, Seiji Kawasaki, Michiie Sakamoto, Shigeki Arii

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The prediction of cancer recurrence holds the key to improvement of the postoperative prognosis of patients. In this study, the recurrence of early-stage hepatocellular carcinoma (HCC) after curative hepatectomy was analyzed by the genome-wide gene-expression profiling on cancer tissue and the noncancerous liver tissue. Using the training set of 78 cases, the cytochrome P450 1A2 (CYP1A2) gene in noncancerous liver tissue was identified as the predictive candidate for postoperative recurrence (hazard ratio [HR], 0.447; 95% confidence interval [CI], 0.249-0.808; P = 0.010). Multivariate analysis revealed the statistically significant advantage of CYP1A2 down-regulation to predict recurrence (odds ratio, 0.534; 95% CI, 0.276-0.916; P = 0.036), and the expression of CYP1A2 protein was confirmed immunohistochemically. An independently multi-institutional cohort of 211 patients, using tissue microarrays, validated that loss of expression of CYP1A2 in noncancerous liver tissue as the only predictive factor of recurrence after curative hepatectomy for early-stage HCC (HR, 0.480; 95% CI, 0.256-0.902; P = 0.038). Gene set-enrichment analysis revealed close association of CYP1A2 down-regulation with oxidative stress pathways in liver tissue (P < 0.001, false discovery rate [FDR] = 0.042; P = 0.006, FDR = 0.035). Our results indicate these pathways as the molecular targets to prevent recurrence, as well as the potential prediction of the super high-risk population of HCC using liver tissue.

Original languageEnglish
Pages (from-to)1273-1281
Number of pages9
JournalHepatology
Volume54
Issue number4
DOIs
Publication statusPublished - 2011 Oct

Fingerprint

Multicenter Studies
Cytochrome P-450 CYP1A2
Hepatocellular Carcinoma
Oxidative Stress
Prospective Studies
Recurrence
Liver
Hepatectomy
Confidence Intervals
Down-Regulation
Gene Expression Profiling
Genes
Neoplasms
Multivariate Analysis
Odds Ratio
Genome
Population
Proteins

ASJC Scopus subject areas

  • Hepatology

Cite this

Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence : A prospective, multicenter study. / Tanaka, Shinji; Mogushi, Kaoru; Yasen, Mahmut; Ban, Daisuke; Noguchi, Norio; Irie, Takumi; Kudo, Atsushi; Nakamura, Noriaki; Tanaka, Hiroshi; Yamamoto, Masakazu; Kokudo, Norihiro; Takayama, Tadatoshi; Kawasaki, Seiji; Sakamoto, Michiie; Arii, Shigeki.

In: Hepatology, Vol. 54, No. 4, 10.2011, p. 1273-1281.

Research output: Contribution to journalArticle

Tanaka, S, Mogushi, K, Yasen, M, Ban, D, Noguchi, N, Irie, T, Kudo, A, Nakamura, N, Tanaka, H, Yamamoto, M, Kokudo, N, Takayama, T, Kawasaki, S, Sakamoto, M & Arii, S 2011, 'Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study', Hepatology, vol. 54, no. 4, pp. 1273-1281. https://doi.org/10.1002/hep.24536
Tanaka, Shinji ; Mogushi, Kaoru ; Yasen, Mahmut ; Ban, Daisuke ; Noguchi, Norio ; Irie, Takumi ; Kudo, Atsushi ; Nakamura, Noriaki ; Tanaka, Hiroshi ; Yamamoto, Masakazu ; Kokudo, Norihiro ; Takayama, Tadatoshi ; Kawasaki, Seiji ; Sakamoto, Michiie ; Arii, Shigeki. / Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence : A prospective, multicenter study. In: Hepatology. 2011 ; Vol. 54, No. 4. pp. 1273-1281.
@article{24131d13f60e41dfba95003975b9067d,
title = "Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study",
abstract = "The prediction of cancer recurrence holds the key to improvement of the postoperative prognosis of patients. In this study, the recurrence of early-stage hepatocellular carcinoma (HCC) after curative hepatectomy was analyzed by the genome-wide gene-expression profiling on cancer tissue and the noncancerous liver tissue. Using the training set of 78 cases, the cytochrome P450 1A2 (CYP1A2) gene in noncancerous liver tissue was identified as the predictive candidate for postoperative recurrence (hazard ratio [HR], 0.447; 95{\%} confidence interval [CI], 0.249-0.808; P = 0.010). Multivariate analysis revealed the statistically significant advantage of CYP1A2 down-regulation to predict recurrence (odds ratio, 0.534; 95{\%} CI, 0.276-0.916; P = 0.036), and the expression of CYP1A2 protein was confirmed immunohistochemically. An independently multi-institutional cohort of 211 patients, using tissue microarrays, validated that loss of expression of CYP1A2 in noncancerous liver tissue as the only predictive factor of recurrence after curative hepatectomy for early-stage HCC (HR, 0.480; 95{\%} CI, 0.256-0.902; P = 0.038). Gene set-enrichment analysis revealed close association of CYP1A2 down-regulation with oxidative stress pathways in liver tissue (P < 0.001, false discovery rate [FDR] = 0.042; P = 0.006, FDR = 0.035). Our results indicate these pathways as the molecular targets to prevent recurrence, as well as the potential prediction of the super high-risk population of HCC using liver tissue.",
author = "Shinji Tanaka and Kaoru Mogushi and Mahmut Yasen and Daisuke Ban and Norio Noguchi and Takumi Irie and Atsushi Kudo and Noriaki Nakamura and Hiroshi Tanaka and Masakazu Yamamoto and Norihiro Kokudo and Tadatoshi Takayama and Seiji Kawasaki and Michiie Sakamoto and Shigeki Arii",
year = "2011",
month = "10",
doi = "10.1002/hep.24536",
language = "English",
volume = "54",
pages = "1273--1281",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence

T2 - A prospective, multicenter study

AU - Tanaka, Shinji

AU - Mogushi, Kaoru

AU - Yasen, Mahmut

AU - Ban, Daisuke

AU - Noguchi, Norio

AU - Irie, Takumi

AU - Kudo, Atsushi

AU - Nakamura, Noriaki

AU - Tanaka, Hiroshi

AU - Yamamoto, Masakazu

AU - Kokudo, Norihiro

AU - Takayama, Tadatoshi

AU - Kawasaki, Seiji

AU - Sakamoto, Michiie

AU - Arii, Shigeki

PY - 2011/10

Y1 - 2011/10

N2 - The prediction of cancer recurrence holds the key to improvement of the postoperative prognosis of patients. In this study, the recurrence of early-stage hepatocellular carcinoma (HCC) after curative hepatectomy was analyzed by the genome-wide gene-expression profiling on cancer tissue and the noncancerous liver tissue. Using the training set of 78 cases, the cytochrome P450 1A2 (CYP1A2) gene in noncancerous liver tissue was identified as the predictive candidate for postoperative recurrence (hazard ratio [HR], 0.447; 95% confidence interval [CI], 0.249-0.808; P = 0.010). Multivariate analysis revealed the statistically significant advantage of CYP1A2 down-regulation to predict recurrence (odds ratio, 0.534; 95% CI, 0.276-0.916; P = 0.036), and the expression of CYP1A2 protein was confirmed immunohistochemically. An independently multi-institutional cohort of 211 patients, using tissue microarrays, validated that loss of expression of CYP1A2 in noncancerous liver tissue as the only predictive factor of recurrence after curative hepatectomy for early-stage HCC (HR, 0.480; 95% CI, 0.256-0.902; P = 0.038). Gene set-enrichment analysis revealed close association of CYP1A2 down-regulation with oxidative stress pathways in liver tissue (P < 0.001, false discovery rate [FDR] = 0.042; P = 0.006, FDR = 0.035). Our results indicate these pathways as the molecular targets to prevent recurrence, as well as the potential prediction of the super high-risk population of HCC using liver tissue.

AB - The prediction of cancer recurrence holds the key to improvement of the postoperative prognosis of patients. In this study, the recurrence of early-stage hepatocellular carcinoma (HCC) after curative hepatectomy was analyzed by the genome-wide gene-expression profiling on cancer tissue and the noncancerous liver tissue. Using the training set of 78 cases, the cytochrome P450 1A2 (CYP1A2) gene in noncancerous liver tissue was identified as the predictive candidate for postoperative recurrence (hazard ratio [HR], 0.447; 95% confidence interval [CI], 0.249-0.808; P = 0.010). Multivariate analysis revealed the statistically significant advantage of CYP1A2 down-regulation to predict recurrence (odds ratio, 0.534; 95% CI, 0.276-0.916; P = 0.036), and the expression of CYP1A2 protein was confirmed immunohistochemically. An independently multi-institutional cohort of 211 patients, using tissue microarrays, validated that loss of expression of CYP1A2 in noncancerous liver tissue as the only predictive factor of recurrence after curative hepatectomy for early-stage HCC (HR, 0.480; 95% CI, 0.256-0.902; P = 0.038). Gene set-enrichment analysis revealed close association of CYP1A2 down-regulation with oxidative stress pathways in liver tissue (P < 0.001, false discovery rate [FDR] = 0.042; P = 0.006, FDR = 0.035). Our results indicate these pathways as the molecular targets to prevent recurrence, as well as the potential prediction of the super high-risk population of HCC using liver tissue.

UR - http://www.scopus.com/inward/record.url?scp=80053305648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053305648&partnerID=8YFLogxK

U2 - 10.1002/hep.24536

DO - 10.1002/hep.24536

M3 - Article

C2 - 22006857

AN - SCOPUS:80053305648

VL - 54

SP - 1273

EP - 1281

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4

ER -